Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $5.2 billion.

  • Roivant Sciences' Liabilities and Shareholders Equity fell 978.84% to $5.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.8 billion, marking a year-over-year decrease of 1928.58%. This contributed to the annual value of $5.4 billion for FY2025, which is 2472.2% down from last year.
  • Per Roivant Sciences' latest filing, its Liabilities and Shareholders Equity stood at $5.2 billion for Q4 2025, which was down 978.84% from $5.1 billion recorded in Q3 2025.
  • Roivant Sciences' 5-year Liabilities and Shareholders Equity high stood at $7.3 billion for Q4 2023, and its period low was $2.1 billion during Q3 2023.
  • Its 5-year average for Liabilities and Shareholders Equity is $4.0 billion, with a median of $3.0 billion in 2021.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 2859.81% in 2022, then soared by 23194.79% in 2023.
  • Over the past 5 years, Roivant Sciences' Liabilities and Shareholders Equity (Quarter) stood at $2.8 billion in 2021, then dropped by 21.31% to $2.2 billion in 2022, then skyrocketed by 231.95% to $7.3 billion in 2023, then fell by 20.79% to $5.8 billion in 2024, then decreased by 9.79% to $5.2 billion in 2025.
  • Its Liabilities and Shareholders Equity was $5.2 billion in Q4 2025, compared to $5.1 billion in Q3 2025 and $5.0 billion in Q2 2025.